BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Clinical trial NCT00077493 · SUSPENDED
Trial details
- NCT number
- NCT00077493
- Sponsor
- MedImmune LLC
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2008-10-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.